|
GOLDENS WITH LYMPHOMA AND OSTEOSARCOMA ARE NEEDED TO STUDY THE
GENETIC BASIS OF LYMPHOMA AND OSTEOSARCOMA The researchers: Dr. Jaime F. Modiano, AMC Cancer Research Center Dr. Mathew Breen, North Carolina State University Eligible participants: Golden Retrievers, Rottweilers, Scottish Deerhounds and Mastiffs ages 4 months to 12 years with lymphoma (grades II-IV and without bone marrow involvement) or osteosarcoma (grades I-II without detectable metastases). These patients should be healthy enough to tolerate x-rays, surgical biopsy and blood draws. After sample submission, lymphoma patients should be treated with standard multi-agent chemotherapy for lymphoma (Vincristine/Adriamycin/Cytoxan/Pred with or without L-asparaginase) and osteosarcoma patients should be treated by surgery (limb amputation or limb-sparing surgery) and systemic chemotherapy. What is needed:
Additional information: A small amount of money (~$250 per eligible lymphoma or bone cancer patient) may be paid by the study to the owners of the affected dogs to help defray costs for the obtaining tumor tissue. Owners of dogs in the study should read the full informed consent regarding study participation. Informed consent for study participation: The document is available online at: http://www.amc.org/pdfs/OwnerConsentForm.pdf For additional information: http://bozman.net/amc/participants.pdf http://www.rottweilerhealth.org/lymphoma_osteo_cancerstudy.html http://mastiff.org/exhibit-hall/health/olcan2.mvContact information: Contact Dr. Modiano at 303-239-3408 or at modianoj@amc.org BEFORE any treatment is started
We believe we will someday prevent this disease in many of our
Goldens – your help is enormously appreciated! |
|
|